Inflammatory markers and loss of muscle mass (sarcopenia) and strength.
By L. Schaap, S. Pluijm, D. Deeg, Marjolein Visser. American Journal of Medicine, 2006
1,019 citations recorded by the source corpus.
Subfields: Geriatrics and Gerontology, Molecular Biology, Physiology
View Paper: https://www.semanticscholar.org/paper/fa51c336020dd900ba5ca57770bf779dff02406a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Physiology
Citations in the corpus
- Sarcopenia: Its assessment, etiology, pathogenesis, consequences and future perspectives (2008, background): “In the Longitudinal Aging Study of Amsterdam, high levels of cytokine IL-6 and CRP were also associated with an increased risk for loss of muscle strength (154).”
- Intermuscular Fat: A Review of the Consequences and Causes (2014, background): “Interestingly, several authors have reported relationships between increased proinflammatory cytokines and decreased muscle [83, 84] and mobility function [85–87] that are strikingly similar to those reported between IMAT and muscle and mobility function [19].”
- Clinical definition of sarcopenia. (2014, background): “(28, 29) reported that TNF-a and its soluble receptors showed the most consistent associations with decline in muscle mass and strength.”
- Skeletal muscle performance and ageing (2017, neutral): “reported to be associated with a two-fold to three-fold risk in losing more than 40% of the muscle strength, after 3 years of follow up,(82) with similar results found for TNF-α.(82,184) Animal studies have demonstrated that TNF-α induced skeletal muscle protein breakdown in rats which lead to signi”
- Inflammation and sarcopenia: A systematic review and meta-analysis. (2017, neutral): “5 Descriptive findings One study [19] reported a no significant difference in monocyte chemoattractant protein-1 (MCP-1) between sarcopenic and no sarcopenic subjects, whereas in a prospective, population-based study suggest higher levels of IL-6 and CRP increase the risk of muscle strength loss in ”